Oragenics Inc (OGEN)-Financial and Strategic SWOT Analysis Review

Oragenics Inc (OGEN)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH63249FSA
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Oragenics Inc (OGEN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oragenics Inc (Oragenics) is a biopharmaceutical company that focuses on the development and commercialization of its novel antibiotics against infectious disease and develops treatments for oral mucositis. The company develops a new class of potent gram-positive antibiotics which are called Lantibiotics for combating resistant bacterial infections. Its lead product candidate, MU1140 is being tested for healthcare associated infections caused by drug-resistant bacteria. The company develops other candidates and technologies in the oral care and weight loss areas which include AG013 for the treatment of oral mucositis in cancer patients; OG716 in preclinical phase for healthcare-associated infections; and LPT3-04 for weight loss. The company sells its product directly and through sales contracts in several countries worldwide. Oragenics is headquartered in Tampa, Florida, the US.

Oragenics Inc Key Recent Developments

Apr 18,2017: Oragenics Provides First Quarter 2017 Update

Jun 06,2016: Oragenics Announces new President, Chief Executive Officer and Member of the Board of Directors

Feb 19,2016: Oragenics Receives New Patent for Improved Replacement Therapy for Dental Caries

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Oragenics Inc-Key Facts 5

Oragenics Inc-Key Employees 6

Oragenics Inc-Key Employee Biographies 7

Oragenics Inc-Major Products and Services 8

Oragenics Inc-Pharmaceutical Pipeline Products Data 9

Oragenics Inc, Pipeline Products by Therapy Area 9

Oragenics Inc, Pipeline Products by Development Phase 10

Oragenics Inc-History 11

Oragenics Inc-Company Statement 14

Oragenics Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Section 2-Company Analysis 19

Oragenics Inc-Business Description 19

Oragenics Inc-SWOT Analysis 20

SWOT Analysis-Overview 20

Oragenics Inc-Strengths 20

Oragenics Inc-Weaknesses 21

Oragenics Inc-Opportunities 22

Oragenics Inc-Threats 23

Oragenics Inc-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Oragenics Inc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Apr 18, 2017: Oragenics Provides First Quarter 2017 Update 34

Jun 06, 2016: Oragenics Announces new President, Chief Executive Officer and Member of the Board of Directors 35

Feb 19, 2016: Oragenics Receives New Patent for Improved Replacement Therapy for Dental Caries 36

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Figures

Oragenics Inc, Pipeline Products by Therapy Area 9

Oragenics Inc, Pipeline Products by Development Phase 10

Oragenics Inc, Performance Chart (2012-2016) 28

Oragenics Inc, Ratio Charts 30

Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Oragenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 32

List of Tables

Oragenics Inc, Key Facts 5

Oragenics Inc, Key Employees 6

Oragenics Inc, Key Employee Biographies 7

Oragenics Inc, Major Products and Services 8

Oragenics Inc, Number of Pipeline Products by Therapy Area 9

Oragenics Inc, Number of Pipeline Products by Development Stage 10

Oragenics Inc, History 11

Oragenics Inc, Other Locations 18

Oragenics Inc, Key Competitors 24

Oragenics Inc, Ratios based on current share price 25

Oragenics Inc, Annual Ratios 26

Oragenics Inc, Annual Ratios (Cont...1) 27

Oragenics Inc, Interim Ratios 29

Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Oragenics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Oragenics Inc, Recent Deals Summary 33

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Oragenics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8044
Site License
USD 250 INR 16088
Corporate User License
USD 375 INR 24131

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com